Evidence Based Investments
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remember, all these have happened during the first
quarter of this year, so perhaps we will hear more
about revenue projections and development.
Sigma Labs and Spartacus3D Sign Agreement for Collaboration in Europe
SANTA FE, N.M. – April 18, 2016 – Sigma Labs, Inc. (OTCQB: SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing (“AM”) and other advanced manufacturing technologies, today announced that the Company is teaming with Spartacus3D, a unit of France’s Farinia Group, to accelerate its presence in Europe. As part of this agreement, Spartacus3D will serve as a demonstration, test and evaluation site for Sigma Labs’ PrintRite3D® commercialization and market adoption activities in Europe.
More
Sigma Labs Signs Agreement with Creatz3D of Singapore
SANTA FE, N.M. – April 4, 2016 – Sigma Labs, Inc. (OTCQB: SGLBD; OTCQB: SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing (“AM”) and other advanced manufacturing technologies, today announced that the Company has signed an agreement with Creatz3D Pte Ltd ("Creatz3D") to be the non-exclusive sales and service agent for Sigma Labs in Singapore, Indonesia and Vietnam. Creatz3D is an authorized reseller of 3D printing systems and materials, AM solutions for metal components, and rapid prototyping software.
More
Sigma Labs Announces Upcoming Industry Events
SANTA FE, N.M. – March 22, 2016 – Sigma Labs, Inc. (OTCQB: SGLBD) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing (“AM”) and other advanced manufacturing technologies, today announced that management would participate in the following industry events this spring:
More
Sigma Labs Announces Fourth Quarter and Full Year Financial Results
Record Revenue – Company Positioned for Strong Growth Going Forward
Announces Reverse Stock Split Effective March 17, 2016 and Stock Repurchase Program
More
Sigma Labs Announces Contracts with Aerojet Rocketdyne for Air Force Program and “America Makes” Initiative
SANTA FE, N.M. – March 7, 2016 – Sigma Labs, Inc. (OTCQB: SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing (“AM”) and other advanced manufacturing technologies, today announced that it has received a contract from Aerojet Rocketdyne, a subsidiary of Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD), for a non-exclusive license of the Company's PrintRite3D® software applications. Terms of the award were not disclosed. Sigma Labs’ technology will be utilized on Aerojet Rocketdyne’s contract with the U.S. Air Force to define more efficient processes for qualifying AM components, and be evaluated for liquid-fueled rocket engine applications. The broader Air Force initiative is part of a plan to transition away from the Russian-made RD-180 engines currently used on the Atlas V launch vehicle.
More
Sigma Labs and 3DSIM Sign Technology Development Agreement for Metal AM
SANTA FE, N.M. – January 27, 2016 – Sigma Labs, Inc. (OTCQB: SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing (“AM”) and other advanced manufacturing technologies, today announced that it has entered into a technology development agreement with 3DSIM to pursue commercial metal AM software opportunities for rapid qualification and part certification. 3DSIM, based in Park City, Utah, is a provider of simulation software for metal AM processes.
The issuance of the extra 7.5 million shares was unfortunate,
but is providing great prices for those who forsee the future
of SGLB tech.
mid 2's and below will be a great price. Only a matter
of time before record revenues continue continue to
be set by sigma. Several licensing deals across the globe
while working with giants such as GE, Honeywell, and Aerojet
Rocketdyne. This tech is no mumbo jumbo.
SGLB will grow with the industry. We'll all be laughing about
how scared we were in 2016 by 2020 or earlier.
Long term growth is immanent for Sigma.
Adding every paycheck.
Yikes. 3. 3.10....idk how far this knife will fall...
Generally, if you are being truthful about your recent purchases (over the past month or so) you have been buying at risky times just based on chart action, which has only became worse, as I'm sure your account shows.
But with our current valuation being the lowest it's been in years, I can't blame anyone for buying.
Last I added was before the rs.
Seems to be a shaky time to add but .034 pre rs, I would have been buying like crazy so it makes sense to buy it now.
I believe SGLB is very close to becoming a real Player in the AM industry. We have the patents and technology no one else does at the present moment. Everyone is pushing towards AM full production, with new publications, case studies, and announcements coming out weekly by several companies.
The recent licensing deals are very eye opening to how infectious this technology can become across the entire industry. This much attention on an OTC company tech? Very promising.
http://www.pw.utc.com/News/Story/20160412-0845
Low rate initial production LRIP sounds a lot like Small Lot Intelligent Manufacturing SLIM by sigma labs.
Hopefully we could land a contract to be part of something similar. This deal was worth 1.4 billion, even a small percentage including IPQA would be a game changer for sglb.
If you wanna talk basics I believe there's probably still a yahoo board for sigma or general investing, but thanks for your concern.
I'm well aware how market cap is calculated.
I was factoring in the reality that our p/e is already rediculous so we obviously need revenues to increase our stock price, thus increasing our market cap.
I'm sure he won't be allowed to comment on that exactly but I was going to phrase those questions as so:
Since the nasdaq listing requirement is 75 million in market cap, and we are at about 30 million, can you break down by percentage where the company feels the remaining 45 million will come from and in what time frame? Ie. 60% from ipqa system sales, 30% from embedding in oem printers, 10% contract manufacturing over the next 2 years. Maybe ask on sales projections
I figure this is the only way I might get a feeling if Honeywell or ge plans on buying a number of ipqa or contour systems.
Just booked my reservations for RAPID 2016
in Orlando.
Taking a few vacation days but it will be well
worth it to see everything going on in the
wonderful world of Additive Manufacturing
and of course with Sigma Labs.
Anyone else plan on attending?
If so, we should do lunch!
If not, I am open to asking questions to the SGLB
employees who are exhibiting, so if you have
any pertinent questions shoot them my way.
Yeah I agree completely. I was hoping an rs wouldn't take place until after a few bigger contracts. But if they continue to put up +100% revenues, profitability isn't too far away.
Still, running low on cash also, this move seemed premature and ill-timed.
Just counting on management's decision to supposedly benefit the shareholders at this point. Time will tell.
S3 can't be utilized until that 75 million market cap, which just so happens to be the nasdaq listing requirement, so my guess is they will build up to that 75 million, uplist, then utilize the s3. How long it will take to get to 75 million may take some time, and the possibility of being shorted in the meantime continues to lurk.
All in all, I would still consider sglb a buy anywhere under a 30 million dollar valuation, as the players they have been cooperating with for years are giants and seem very interested in our core product.
Also SGLB has many cooperation agreements floating around, which although useless now, show overall interest within the industry, especially with AM machine producers directly embedding sglb tech inside.
As AM continues to take off, SGLB appears to be well positioned to be included in the market share.
Exciting times nontheless.
With our current valuation and aggressive p/e ratio, we need to triple our sales just to be able to uplist. And that's hoping we can hold our high p/e ratio which is unlikely once we get to a nasdaq listing and the shorters come in and see our dismal balance sheet.
MC needs more than his ducks in a row, he needs a ducks, a couple geese and a swan in order to for an uplisting anytime soon. Hopefully he can pull something off without dilution via the s3 or at least present some sales before utilizing that.
Next ER should spread some clarity on the future, I urge investors to attend the call and ask Mark the plan of action, I attempted but he dodged my question by only saying they plan to increase revenues and explore the s3 options.
Maybe if we throw a few different questions at him we will actually get an answer.
The most important part of the contract with Creatz is that it specifies they will handle the sales AND service of ipqa systems.
If they are truly capable of doing this, it would prove sglb could easily license this technology to just about anyone. This would limit our need to hire an extensive customer support and technical support team.
Low overhead, low staffing costs, higher margins. Sounds good to me.
I hope they're selling those key chains for 100k a piece! Lol
Cheers fellow Sigmaniacs!
I agree and am fearful of the same thing.
Companies with a much stronger balance sheet can be destroyed by moves like this.
Our balance sheet is dismal.
This can get bad quick.
This is what I was trying to ask Mark in the last conference call what the plan was and all he said was that they were going to explore options.
Basically they need to sign major contracts with cash that makes it directly onto the following ER.
As of now we are in limbo, hoping sglb can produce the numbers mark has been hinting at over the last few conference calls.
Mark seems to think business will pick up enough over 2016 to solidify their current valuation. However, for this to happen, sglb will need to produce at least a few million in orders over the next couple quarters.
It's a huge leap of faith here. But Mark hasn't spoken on a plan other than they expect business to pick up.
Hopefully the financial advisors of the company understand what is needed to happen otherwise we will see a substantial loss from our current valuation.
Well put.
Timing may be "right" in a long term scenario, but right now, with no sales, contracts, or cash coming in or announced in last ER, the short term timing could be a very shaky time for the stock price and those who may have been aggressively investing may get burned.
If there aren't large contracts or fund raising soon, we could easily lose a large chunk of our market valuation as we currently have no sales, cash, or distribution.
Cola either has something big coming, or had to take this hit and pretend like everything is OK to meet uplisting requirements, when in reality we are really just waiting to be shorted to oblivion until we slowly earn enough money to uplist.
Might wanna save some cash coming up...unfortunately, without contracts, cash, and sales, this rs may have been premature unless sglb has something big up their sleeves Very soon. I've seen many other companies do this and lose a great portion of their market valuation.
Not saying we are doomed, just heeding warning to fellow sglb investors.
Good luck to all.
You're right, unless we are saved by a large contract of which we supposedly have many in the works.
Time will tell.
I'll buy all the way down
Nope, same boat.
SGLBD showing -.21 at
$5.00 share price
Thanks for the support and understanding of the logic here.
and sglb lost 1.7 million on the year...so whats your
point?
how are they so different?
Oncosec, 30 million in cash, 37 million market valuation. only slightly above.
Ensync, 48 million in assets, 14 million market valuation.
Go teach gym class.
It all comes down to brass tax.
Money is how this is all run.
Patents and all the things you are referring
to mean nothing if they arent making large sums
of money, which as of right now, they arent.
So teach all you want, we are currently over valued
and could easily see a drop if they do not post revenues
soon.
most of them are until they post revenues!
Companies are valued based on their cash and sales.
Our cash (1.1 million) and sales (1.2 million)
Book Value around 3 million.
Our market valuation 37 million
That is over 10X book value which is crazy for
a company with 10 employees and low sales, low cash,
no distribution network.
The S3 will need to be utilized to meet listing requirements and
attract institutional investors.
The hope with sigma was that they would post revenues from GE or
Honeywell before making these moves.
Unfortunately this is not the case.
I pray to God that they post big revenues before utilizing the S3
otherwise we will be diluted to a market cap around 5-10 million at best.
Hopefully they are able to post revenues before the next ER otherwise
it will be 3 months of shorting and our valuation dwindling to nothing.
Still around 10x to get to our current market valuation, which means we will
be shorted until it is down to 2x.
Which means this will go from about 5.50 to $2 in a few months
unless huge revenues and the S3 is reported and our book value
increases SIGNIFICANTLY between now and the next ER which
we wont really know for sure until the next ER 3 months from now.
Our Current Book value is 2.7 million
and our market valuation is 37 million.
Big investors will short the bejesus out
of this since our balance sheet is deplorable.
We Need CASH and SALES ASAP.
Tmrw might not be so pretty.
Save your cash and buy some discounted shares
until those revenues are posted. This could
get ugly.
Ive seen companies with 30 million in cash lose
50% of their valuation after a RS bc they didnt
have and sales coming in.
SGLB better have a trick up their sleeve real soon.
SGLB only has 1 mill in cash and 2.7 in total shareholder value with a market cap of 37 million. Thats over 10x their valuation which is very high. This split might hurt at first until they post revenues and get some cash on that balance sheet. Time will tell i suppose.
From a recent AM webinar I attended.
My question is featured at approximately
57:15 of the video.
Very information webinar in whole.
You're Welcome,
Enjoy
https://attendee.gotowebinar.com/recording/viewRecording/82570396562709762/6415239503415719427/kmey3434@yahoo.com
Even if PR3D reaches the 5% market share mark of the AM industry, we will see are valuation grow rapidly as the market grows, which is expected to be well over the $20 billion mark in the upcoming years.
Of course SGLB isn't the only player.
No one thinks that, that is just silly.
Will they be a competitor? Most definitely.
Not sure if any of you were a part of the AM webinar today, but during the Q&A I asked if in-process quality assurance technologies were being applied to qualify FAA and FDA parts.
The answer was a definite Yes.
If fact the speaker went on to say that many AM printer makers are integrating this type of software directly into their products.
The speaker referenced "in-situ inspection processes" as emerging and becoming commercially available.
Company value is determined by valuation of market cap based on shares and the price of those shares.
Based on our current valuation we are overvalued, but have been able to hold our approximately 30-40 million dollar valuation for quite some time.
That valuation is based on our connections with ge and Honeywell as it is obviously not based on our financials otherwise it would be much lower.
Since most companies eventually, especially when uplisting, see their valuation reflect financials, it is fair to say we may see a decline after a r/s and or utilization of the s3 to raise funds to uplist if the balance sheet is still in need of addition funds to reach uplisting requirements.
Sglb has a long way to go but we are well positioned and poised for growth to secure a fair valuation.
I was under the impression 3dsim predicts the print as it is occurring. I would feel much better if their tech was for before the print as to during.
I'm not sure though I haven't had time to do proper research on their publications and patents.
I'm aware 3dsim was already working with them, just wondering if their tech will be necessary for qualification, as I hope ours will be necessary. I'm wondering if their tech will be an add-on for those who want the most advanced technology, and sglb tech will be the meat of the qualification process.
Interesting news today.
I wish 3dsim was more of a developed company with sales or at least a public one with financial information available.
Not sure how i feel about "needing" their technology in this collaboration as a good thing or a bad thing. Could cut into our profits if its determined their tech significantly supplements ours. Nonetheless seems to be on the up and up.
Glta.
Interesting coincidence that the America Makes
Project ran by GE aviation in collaboration with
-Aerojet Rocketdyne, Honeywell, Burke E. Porter,
SIGMA LABS, Techsolve, and Montana Tech
To find an IPQA solution in a commercially available
platform ends on 3/15/16. Just in time for SGLB
conference call the day after.
Hopefully they will have something very interesting
to say about the project.
Entire market seems to be enjoying a nice
little pop today from the recent almost
full year of punishment. I suspect there
will be a leveling off for another few months
as everything settles into place.
With still 2 months to go before we see any
real numbers from SGLB I also suspect we will
hang out around our 52 week lows at .042, I
will continue to add near those prices.
I am just hoping SGLB will make enough money
in the short term to continue operations
without utilizing the S3 before making any
substantial amount of money bc that kind
of dilution would certainly send us below
.042.
Maybe our Arete venture will put some money on
the board or a new customer comes along soon.
Either way we need some cash before we start heading
into a debt situation or early dilution, even though
we are technically overvalued and overpaying for
shares at the moment, I would like to believe that
SGLB could make some sales to earn us the valuation
we sit at before uplisting so when we do uplist we
dont get shorted to oblivion if our valuation is still
as ridiculously high as it is now.
Just some thoughts of the day. GLTA
*latest news
No lol, just ask if there is any news. Not new news, not newer news as neither make grammatical sense. Just news lmao.
Saying new news is redundant.
News is new, hence the "new" in news.